Scorpius Holdings Files 8-K on Security Holder Rights & Bylaws
Ticker: SCPX · Form: 8-K · Filed: Jan 16, 2025 · CIK: 1476963
| Field | Detail |
|---|---|
| Company | Scorpius Holdings, Inc. (SCPX) |
| Form Type | 8-K |
| Filed Date | Jan 16, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0002 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, rights
Related Tickers: SCPX
TL;DR
SCPX filed an 8-K detailing changes to security holder rights and corporate governance. Watch for shareholder impact.
AI Summary
Scorpius Holdings, Inc. filed an 8-K on January 16, 2025, reporting material modifications to security holder rights, amendments to its articles of incorporation or bylaws, and submission of matters to a vote of security holders. The filing also includes Regulation FD disclosures and financial statements/exhibits. Scorpius Holdings, Inc. was formerly known as NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.
Why It Matters
This 8-K filing indicates significant corporate actions by Scorpius Holdings, Inc., potentially impacting the rights and governance structure for its security holders.
Risk Assessment
Risk Level: medium — Filings related to modifications of security holder rights and amendments to corporate governance documents can introduce uncertainty and potential risks for investors.
Key Players & Entities
- Scorpius Holdings, Inc. (company) — Registrant
- NightHawk Biosciences, Inc. (company) — Former company name
- HEAT BIOLOGICS, INC. (company) — Former company name
- January 16, 2025 (date) — Date of earliest event reported
FAQ
What specific material modifications were made to the rights of Scorpius Holdings, Inc. security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the provided text excerpt. Further review of the full filing is required.
What were the key amendments to Scorpius Holdings, Inc.'s articles of incorporation or bylaws?
The filing states that amendments to the articles of incorporation or bylaws were submitted, but the specific content of these amendments is not detailed in the provided text.
What matters were submitted to a vote of Scorpius Holdings, Inc. security holders?
The filing confirms that matters were submitted to a vote of security holders, but the nature of these matters is not specified in the excerpt.
When did Scorpius Holdings, Inc. change its name from NightHawk Biosciences, Inc.?
Scorpius Holdings, Inc. changed its name from NightHawk Biosciences, Inc. on May 2, 2022.
What is the primary business of Scorpius Holdings, Inc. according to its SIC code?
According to its Standard Industrial Classification (SIC) code, Scorpius Holdings, Inc. is involved in Pharmaceutical Preparations.
Filing Stats: 1,600 words · 6 min read · ~5 pages · Grade level 11.9 · Accepted 2025-01-16 17:01:34
Key Financial Figures
- $0.0002 — nge on which registered Common Stock, $0.0002 par value per share SCPX NYSE America
Filing Documents
- scpx_8k.htm (8-K) — 46KB
- ex3x1.htm (EX-3.1) — 7KB
- ex99x1.htm (EX-99.1) — 7KB
- image_001.jpg (GRAPHIC) — 10KB
- 0001079973-25-000094.txt ( ) — 296KB
- scpx-20250116.xsd (EX-101.SCH) — 3KB
- scpx-20250116_def.xml (EX-101.DEF) — 26KB
- scpx-20250116_lab.xml (EX-101.LAB) — 36KB
- scpx-20250116_pre.xml (EX-101.PRE) — 25KB
- scpx_8k_htm.xml (XML) — 5KB
03. Material Modification to Rights of Security Holders
Item 3.03. Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information regarding the Reverse Stock Split (as defined below) contained in Item 5.03 of this Current Report on Form 8-K is incorporated by reference in this Item 3.03.
03. Amendments to Articles of Incorporation or Bylaws
Item 5.03. Amendments to Articles of Incorporation or Bylaws. Reverse Split At the Special Meeting of Stockholders (the "Special Meeting") of Scorpius Holdings, Inc. (the "Company") held on January 16, 2025, the Company's stockholders approved a proposal granting the Company's Board of Directors (the "Board") the discretion to amend the Company's Third Amended and Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), to effect a reverse stock split of the Company's common stock, par value $0.0002 per share (the "Common Stock"), at a ratio of 1-for-5 to 1-for-35, with the ratio within such range to be determined at the discretion of the Board, without reducing the authorized number of shares of Common Stock. Following the Special Meeting, the Board approved the filing of a Certificate of Amendment to the Certificate of Incorporation (the "Charter Amendment") to effect a reverse stock split at a final split ratio of 1-for-20 (the "Reverse Stock Split"). The Company intends to file the Charter Amendment with the Secretary of State of the State of Delaware to effect the Reverse Stock Split on January 17, 2025, to become effective at 12:01 a.m. Eastern Time on January 21, 2025 (the "Effective Date"). Split Adjustment; Treatment of Fractional Shares As a result of the 1-for-20 Reverse Stock Split, each 20 pre-split shares of Common Stock outstanding will automatically combine into one new share of Common Stock without any action on the part of the holders, and the number of outstanding shares of Common Stock will be reduced from approximately 5.8 million shares to approximately 0.3 million shares (subject to rounding of fractional shares, which will be paid in cash). Proportional adjustments will also be made to the number of shares of Common Stock issuable upon exercise or conversion of the Company's outstanding equity awards and warrants, as well as the applicable exercise price. The Reverse Stock Split will affect all of the Com
07. Submission of Matters to a Vote of Security
Item 5.07. Submission of Matters to a Vote of Security Holders. As set forth in Item 5.03 of this Current Report on Form 8-K, on January 16, 2025, the Company held the Special Meeting at which the Company's stockholders voted on the following three (3) proposals and cast their votes as described below. These matters are described in detail in the Company's definitive proxy statement on Schedule 14A, which was filed with the Securities and Exchange Commission (the "Commission") on December 20, 2024 (the "Proxy Statement"). As of December 13, 2024, the record date of the Special Meeting, there were 4,868,268 shares of Common Stock issued and outstanding and entitled to vote at the Special Meeting. Present in person or by proxy at the Special Meeting were 2,449,800 shares of Common Stock, representing more than one-third of the issued and outstanding capital stock entitled to vote at the Special Meeting, which constituted a quorum. The final voting results for each item of business voted upon at the Special Meeting, as described in the Proxy Statement, is set forth below. Proposal 1. Reverse Stock Split Proposal. The stockholders approved an amendment to the Company's Third Amended and Restated Certificate of Incorporation, as amended, to, at the discretion of the Board, effect a reverse stock split at a ratio of 1-for-5 to 1-for-35, with the ratio within such range to be determined at the discretion of the Board, based on the votes listed below: Votes For Votes Against Abstentions Broker Non-Votes 1,730,300 709,287 10,213 0 Proposal 2. Share Issuance Proposal. The stockholders approved, for purposes of complying with the NYSE American LLC (the "NYSE American") listing rules, the issuance of 20% or more of the Company's issued and outstanding Common Stock as of December 5, 2024 pursuant to a securities purchase agreement with the purchasers named therein, dated December 5, 2024, including upon the conversion of the senior secured convertible notes and
01. Other Events
Item 7.01. Other Events. In addition, on January 16, 2025, the Company issued a press release relating to the Reverse Stock Split described in this Current Report on Form 8-K. A copy of the press release attached as Exhibit 99.1 to this report is being furnished and incorporated by reference into this Item 7.01 and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this Item 7.01 and the accompanying exhibit shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 3.1 Form of Certificate of Amendment of the Company's Third Amended and Restated Certificate of Incorporation, as amended. 99.1 Press Release dated January 16, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 16, 2025 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer